Literature DB >> 21460009

Polymerase chain reaction detection of Leishmania kDNA from the urine of Peruvian patients with cutaneous and mucocutaneous leishmaniasis.

Nicolas Veland1, Diego Espinosa, Braulio Mark Valencia, Ana Pilar Ramos, Flor Calderon, Jorge Arevalo, Donald E Low, Alejandro Llanos-Cuentas, Andrea K Boggild.   

Abstract

We hypothesized that Leishmania kDNA may be present in urine of patients with cutaneous leishmaniasis (CL). Urine samples and standard diagnostic specimens were collected from patients with skin lesions. kDNA polymerase chain reaction (PCR) was performed on samples from patients and 10 healthy volunteers from non-endemic areas. Eighty-six of 108 patients were diagnosed with CL and 18 (21%) had detectable Leishmania Viannia kDNA in the urine. Sensitivity and specificity were 20.9% (95% confidence interval [CI] 12.3-29.5%) and 100%. Six of 8 patients with mucocutaneous involvement had detectable kDNA in urine versus 12 of 78 patients with isolated cutaneous disease (P < 0.001). L. (V.) braziliensis (N = 3), L. (V.) guyanensis (N = 6), and L. (V.) peruviana (N = 3) were identified from urine. No healthy volunteer or patient with an alternate diagnosis had detectable kDNA in urine. Sensitivity of urine PCR is sub-optimal for diagnosis. On the basis of these preliminary data in a small number of patients, detectable kDNA in urine may identify less localized forms of infection and inform treatment decisions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21460009      PMCID: PMC3062448          DOI: 10.4269/ajtmh.2011.10-0556

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  41 in total

1.  Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.

Authors:  T R Navin; B A Arana; F E Arana; A M de Mérida; A L Castillo; J L Pozuelos
Journal:  Am J Trop Med Hyg       Date:  1990-01       Impact factor: 2.345

Review 2.  Mucosal leishmaniasis ("espundia" Escomel, 1911).

Authors:  P D Marsden
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

Review 3.  Molecular diagnosis of leishmaniasis.

Authors:  Carlos Alberto P Tavares; Ana Paula Fernandes; Maria Norma Melo
Journal:  Expert Rev Mol Diagn       Date:  2003-09       Impact factor: 5.225

4.  Diagnosis of Leishmania using the polymerase chain reaction: a simplified procedure for field work.

Authors:  M Lopez; R Inga; M Cangalaya; J Echevarria; A Llanos-Cuentas; C Orrego; J Arevalo
Journal:  Am J Trop Med Hyg       Date:  1993-09       Impact factor: 2.345

5.  Culture-independent species typing of neotropical Leishmania for clinical validation of a PCR-based assay targeting heat shock protein 70 genes.

Authors:  Lineth Garcia; Ann Kindt; Hernan Bermudez; Alejandro Llanos-Cuentas; Simonne De Doncker; Jorge Arevalo; Kelly Wilber Quispe Tintaya; Jean-Claude Dujardin
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

6.  Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study.

Authors:  L Weinrauch; F Cawich; P Craig; J X Sosa; J el-On
Journal:  J Am Acad Dermatol       Date:  1993-09       Impact factor: 11.527

7.  Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.

Authors:  Rodrigo X Armijos; M Margaret Weigel; Manuel Calvopiña; Manuel Mancheno; Roberto Rodriguez
Journal:  Acta Trop       Date:  2004-07       Impact factor: 3.112

8.  Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis.

Authors:  A Barral; J Guerreiro; G Bomfim; D Correia; M Barral-Netto; E M Carvalho
Journal:  Am J Trop Med Hyg       Date:  1995-09       Impact factor: 2.345

9.  Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.

Authors:  A Asilian; A Sadeghinia; G Faghihi; A Momeni
Journal:  Int J Dermatol       Date:  2004-04       Impact factor: 2.736

10.  Recurrent lesions in human Leishmania braziliensis infection--reactivation or reinfection?

Authors:  N G Saravia; K Weigle; I Segura; S H Giannini; R Pacheco; L A Labrada; A Goncalves
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

View more
  12 in total

Review 1.  Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis.

Authors:  Ciro Martins Gomes; Suleimy Cristina Mazin; Elisa Raphael dos Santos; Mariana Vicente Cesetti; Guilherme Albergaria Brízida Bächtold; João Henrique de Freitas Cordeiro; Fabrício Claudino Estrela Terra Theodoro; Fabiana dos Santos Damasco; Sebastián Andrés Vernal Carranza; Adriana de Oliveira Santos; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-03-31       Impact factor: 2.743

2.  Case Report: Mucosal Leishmaniasis Presenting with Nasal Septum Perforation after Almost Thirty Years.

Authors:  Jesùs Rojas-Jaimes; Helena L Frischtak; Jose Arenas; Andres G Lescano
Journal:  Am J Trop Med Hyg       Date:  2018-05-31       Impact factor: 2.345

3.  Detection of Plasmodium knowlesi DNA in the urine and faeces of a Japanese macaque (Macaca fuscata) over the course of an experimentally induced infection.

Authors:  Satoru Kawai; Megumi Sato; Naoko Kato-Hayashi; Hisashi Kishi; Michael A Huffman; Yoshimasa Maeno; Richard Culleton; Shusuke Nakazawa
Journal:  Malar J       Date:  2014-09-19       Impact factor: 2.979

Review 4.  Urine-Based Molecular Diagnostic Tests for Leishmaniasis Infection in Human and Canine Populations: A Meta-Analysis.

Authors:  Styliani A Pappa; Panagiota I Kontou; Pantelis G Bagos; Georgia G Braliou
Journal:  Pathogens       Date:  2021-02-27

Review 5.  Diagnosing point-of-care diagnostics for neglected tropical diseases.

Authors:  Mitasha Bharadwaj; Michel Bengtson; Mirte Golverdingen; Loulotte Waling; Cees Dekker
Journal:  PLoS Negl Trop Dis       Date:  2021-06-17

6.  Comparison of Three In-House Real PCR Assays Targeting Kinetoplast DNA, the Small Subunit Ribosomal RNA Gene and the Glucose-6-Phosphate Isomerase Gene for the Detection of Leishmania spp. in Human Serum.

Authors:  Konstantin Tanida; Carsten Balczun; Andreas Hahn; Alexandra Veit; Beatrice Nickel; Sven Poppert; Patrick Leander Scheid; Ralf Matthias Hagen; Hagen Frickmann; Ulrike Loderstädt; Egbert Tannich
Journal:  Pathogens       Date:  2021-06-30

7.  Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig model.

Authors:  Yagahira E Castro-Sesquen; Robert H Gilman; Verónica Yauri; Jaime Cok; Noelia Angulo; Hermes Escalante; Caryn Bern
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

8.  Applicability of kDNA-PCR for routine diagnosis of American tegumentary leishmaniasis in a tertiary reference hospital.

Authors:  Marcela M Satow; Edite H Yamashiro-Kanashiro; Mussya C Rocha; Luiza K Oyafuso; Rita C Soler; Paulo C Cotrim; José Angelo L Lindoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Nov-Dec       Impact factor: 1.846

9.  Comprehensive characterization of plasma cell-free Echinococcus spp. DNA in echinococcosis patients using ultra-high-throughput sequencing.

Authors:  Jingkai Ji; Bin Li; Jingzhong Li; Wangmu Danzeng; Jiandong Li; Yanping Zhao; Gezhen Qiangba; Qingda Zhang; Nibu Renzhen; Zhuoga Basang; Changlin Jia; Quzhen Gongsang; Jinmin Ma; Yicong Wang; Fang Chen; Hongcheng Zhou; Jiefang Yin; Jiandan Xie; Na Pei; Huimin Cai; Huayan Jiang; Huanming Yang; Jian Wang; Xiumin Han; Junhua Li; Weijun Chen; Dong Yang
Journal:  PLoS Negl Trop Dis       Date:  2020-04-13

Review 10.  Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing.

Authors:  Dongsheng Han; Rui Li; Jiping Shi; Ping Tan; Rui Zhang; Jinming Li
Journal:  Theranostics       Date:  2020-04-07       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.